Ashime Sh. Asanova , Elena N. Primysheva
Abstract
The article is dedicated to the influence of intestinal microflora on the course of many mental illnesses. For decades, the dominant paradigm in the medical literature has been that the microorganisms present in the intestine are commensals that benefit us by destroying pathogenic bacteria. More recent studies show that these symbionts also play an important role in helping to digest food, produce necessary metabolites, and participate in the development of the immune system. The results of the authors of scientific papers were analyzed, who concluded that microorganisms in the intestine can produce neuroactive molecules that promote interaction between the intestine and the brain, thereby affecting the clinic of many mental diseases.
Keywords: microbiota, bacteria, gut–microbiota–brain axis, mental illness, depression, schizophrenia.
About the Author
Ashime Sh. Asanova 1 , Elena N. Primysheva 11 Vernadsky Crimean Federal University, Institute "Georgievsky Medical Academy" (structural subdivision), Simferopol, Russia
References
1. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Эпидемиологические характеристики сахарного диабета в Российской Федерации: клинико-статистический анализ по данным регистра сахарного диабета на 01.01.2021. Сахарный диабет. 2021; 24 (3): 204–21. DOI: 10.14341/DM12759 [Dedov I.I., SHestakova M.V., Vikulova O.K. et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes Care. 2021; 24 (3): 204–21. DOI: 10.14341/DM12759 (in Russian).]
2. WHO. http://www.emro.who.int/noncommunicable-diseases/ diabetes/index.html
3. Bommer C, Sagalova V, Heesemann E et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care 2018; 41 (5): 963–70. DOI: 10.2337/dc17-1962
4. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44 (8): 968–83.
5. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321 (7258): 405–12. DOI: 10.1136/bmj.321.7258.405
6. Harding JL, Pavkov ME, Magliano DJ et al. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62 (1): 3–16. DOI: 10.1007/s00125-018-4711-2
7. Дедов И.И., Шестакова М.В. Феномен «метаболической памяти» в прогнозировании риска развития сосудистых осложнений при сахарном диабете. Терапевтический архив. 2015; 87 (10): 4–10. DOI: 10.17116/terarkh201587104-10 [Dedov I.I., Shestakova M.V. The metabolic memory phenomenon in predicting a risk for vascular complications in diabetes mellitus. Terapevticheskij arhiv. 2015; 87 (10): 4–10. DOI: 10.17116/terarkh201587104-10 (in Russian).]
8. Roberto T, Rita BA, Prattichizzo F et al. The “Metabolic Memory” theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients 2017; 9 (5): 437. DOI: 10.3390/ nu9050437
9. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск (дополненный). М., 2021. DOI: 10.14341/DM12802 [Standards of specialized diabetes care. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 10 Edition (revised). Moscow, 2021. DOI: 10.14341/DM12802 (in Russian).]
10. ADA Professional Practice Committee. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022; 45 (Suppl. 1): S125-S143. DOI: 10.2337/dc22- S009
11. Егшатян Л.В., Бирюкова Е.В. Влияния железодефицитной анемии на значения гликированного гемоглобина. Лечение и профилактика. 2015; 2 (14): 60–4. [Egshatyan L.V., Biryukova E.V. Vliyaniya zhelezodeficitnoj anemii na znacheniya glikirovannogo gemoglobina. Lechenie i profilaktika. 2015; 2 (14): 60–4 (in Russian).]
12. Bloomgarden Z, Handelsman Y. How does CKD affect HbA1c? J Diabetes 2018; 10 (4): 270. DOI: 10.1111/1753-0407.12624
13. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003; 26 (3): 881–5. DOI: 10.2337/ diacare.26.3.881
14. Кононенко И.В., Смирнова О.М. Значение комплексного контроля гликемии при сахарном диабете 2-го типа. Проблемы эндокринологии. 2010: 5; 43–51. [Kononenko I.V., Smirnova O.M. Znachenie kompleksnogo kontrolya glikemii pri saharnom diabete 2-go tipa. Problemy endokrinologii. 2010: 5; 43–51 (in Russian).]
15. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии – основа эффективного лечения сахарного диабета. Эффективная фармакотерапия. Эндокринология. 2014; 46 (5): 62–72. [Majorov A.Yu., Mel'nikova O.G., Filippov Yu.I. Samokontrol' glikemii – osnova effektivnogo lecheniya saharnogo diabeta. Effektivnaya farmakoterapiya. Endokrinologiya. 2014; 46 (5): 62–72 (in Russian).]
16. Moström P, Ahlén E, Imberg H et al. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes Res Care 2017; 5 (1): e000342. DOI: 10.1136/bmjdrc-2016- 000342
17. Rossi MC, Lucisano G, Ceriello A et al. AMD Annals-SMBG Study Group. Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement. Acta Diabetol 2018; 55 (10): 1059–66. DOI: 10.1007/s00592-018-1186-z
18. Анциферов М.Б., Котешкова О.М. Управление сахарным диабетом: значение структурированного самоконтроля. Фарматека. 2014; 5 (278): 81–5. [Anciferov M.B., Koteshkova O.M. Upravlenie saharnym diabetom: znachenie strukturirovannogo samokontrolya. Farmateka. 2014; 5 (278): 81–5 (in Russian).]
19. Molfetta SD, Bosi E, Ceriello A et al. Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial. Diabetes Res Clin Pract 2021; 181: 109070. DOI: 10.1016/j.diabres.2021.109070
20. Pacheco A, van de Sande-Lee S, Sandova R et al. Effects of a structured education program on glycemic control in type 1 diabetes. Arch Endocrinol Metab 2017; 61 (6): 534–41. DOI: 10.1590/2359-3997000000278
21. Hansen MV, Pedersen-Bjergaard U, Heller SR et al. Frequency and motieves of blood glucose self-monitoring in type 1 diabetes: association with glycaemic control, complications, and patient characteristics. Diabetes Res Clin Pract 2009; 85 (2): 183–8. DOI: 10.1016/j.diabres.2009.04.022
22. Кузина И.А., Гончарова Е.В., Мартиросян Н.С. и др. Исторические аспекты диагностики и контроля сахарного диабета. Терапевтический архив. 2022; 94 (10): 1216–20. DOI: 10.26442/ 00403660.2022.10.201890 [Kuzina I.A., Goncharova E.V., Martirosyan N.S. et al. Historical aspects of diagnosis and control of diabetes mellitus. Terapevticheskij arhiv. 2022; 94 (10): 1216–20. DOI: 10.26442/00403660.2022. 10.201890 (in Russian).]
23. Knapp S, Manroa P, Doshi K. Self-monitoring of blood glucose: Advice for providers and patients. Cleveland Clin J Med 2016, 83 (5): 355–60. DOI: 10.3949/ccjm.83a.14147
24. Bode BW. The Accuracy and Interferences in Self-monitoring of Blood Glucose. US Endocrine Disease 2007: 46–8. DOI: 10.17925/ USE.2007.00.2.46
25. Sia HK, Kor CT, Tu ST. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Scientific Reports 2021; 11 (1): 1176. DOI: 10.1038/s41598-021-81024-x
26. Machry RV, Rados DV, Gregório GR, Rodrigues TC. Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: a systematic review and meta-analysis. Diabetes Res Clin Pract 2018; 142: 173–87. DOI: 10.1016/j.diabres.2018.05.037
27. Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: A metaanalysis of randomized controlled trials. J Diabetes Sci Technol 2018; 12: 183–9. DOI: 10.1177/1932296817719290
28. Lalić NM, Lalić K, Jotić A et al. The Impact of Structured Self-Monitoring of Blood Glucose Combined With Intensive Education on HbA1c Levels, Hospitalizations, and Quality-of-Life Parameters in Insulin-Treated Patients With Diabetes at Primary Care in Serbia: The Multicenter SPA-EDU Study. J Diabetes Sci Technol 2017; 11 (4): 746–52. DOI: 10.1177/1932296816681323
29. Schnell O, Alawi H, Battelino T et al. Self-monitoring of blood glucose in type 2 diabetes: recent studies. J Diabetes Sci Technol 2013; 7: 478–88. DOI: 10.1177/193229681300700225
30. Ziegler R, Heidtmann B, Hilgard D et al. Frequency of SMBG Correlates with HbA1c and Acute Complications in Children and Adolescents with Type 1 Diabetes. Pediatr Diabetes 2011; 12 (1): 11–17. DOI: 10.1111/j.1399-5448.2010.00650.x
31. Tomah S, Mahmoud N, Mottalib A et al. Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity. BMJ Open Diab Res Care 2019; 7 (1): e000659. DOI: 10.1136/bmjdrc-2019-000659
32. Schnell O, Alawi H, Battelino T et al. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation. Diabetes Technol Ther 2011; 13 (9): 959–65. DOI: 10.1089/dia.2011.0028
33. Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol 2009; 3 (4): 971–80. DOI: 10.1177/193229680900300446 Литература / References 82 | КЛИНИЧЕСКИЙ РАЗБОР В ОБщЕЙ МЕДИЦИНЕ | ТОМ 4 | №2 | 2023 | Clinical review for general practice | vol. 4 | no. 2 | 2023 | Обзор / Review
34. International Organization for Standardization. International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013. www.iso.org/obp/ui/ #iso:std:iso:15197:ed-2:v1:en
35. Bailey T, Wallace JF, Christiansen M. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technology 2017; 11 (4): 736–43. DOI: 10.1177/1932296816680829
36. Pardo S, Shaginian RM, Simmons DA. Accuracy beyond ISO: Introducing a new method for distinguishing differences between blood glucose monitoring systems meeting ISO 15197:2013 accuracy requirements. J Diabetes Sci Technol 2018; 12 (3): 650–6. DOI: 10.1177/1932296818762509
37. Stedman M, Rea R, Duff CJ et al. People with type diabetes mellitus (T1DM) self-reported views on their own condition management reveal links to potentially improved outcomes and potential areas for service improvement. Diabetes Res Clin Pract 2020; 170: 108479. DOI: 10.1016/j.diabres.2020.108479
38. Stedman M, Rea R, Duff CJ et al. Self-reported views on managing type 1 diabetes mellitus. J Diabetes Sci Technol 2021; 15 (1): 198–200. DOI: 10.1177/1932296820937771
39. Campos-Náñez E, Breton MD. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study J Diabetes Sci Technol. 2017; 11 (6): 1196–206. DOI: 10.1177/1932296817710476
For citation:Asanova A.Sh., Primysheva E.N. To the question of the influence of intestinal microflora on the course of mental diseases. Clinical review for general practice. 2023; 4 (2): 77–82. DOI: 10.47407/kr2023.4.2.00208
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.